ASPIRE Study

ASPIRE Study
204291

Number of Participants

350

Eligibility

Ventricular tachycardia, drug refractory (including beta-blockers), ICD implanted, history of MI

Purpose

The purpose of this study is to determine if early ablation and medical therapy is more effective than medical therapy alone in treating ventricular tachycardia.

Treatment

Participants will be randomly assigned to receive ablation and medical therapy, or medical therapy alone for the treatment of ventricular arrhythmias.

Principal Investigator

David J. Wilber

M.D., FAHA, FACC
Cardiology
George M. Eisenberg Professor of Cardiovascular Sciences

Enrollment

(708) 216-2646

More Clinical Trials

See Also

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy